Canadian trial tests monkeypox drug in outpatients
Disease control
Terminated
This Canadian study tests whether the antiviral drug tecovirimat (TPOXX) helps non-hospitalized adults with monkeypox recover faster. About 120 participants will receive either the drug or a placebo. The main goal is to see how quickly skin lesions heal and whether running such a…
Phase: PHASE3 • Sponsor: Marina Klein • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC